1. Home
  2. BCSF vs EMBC Comparison

BCSF vs EMBC Comparison

Compare BCSF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCSF
  • EMBC
  • Stock Information
  • Founded
  • BCSF 2015
  • EMBC 1924
  • Country
  • BCSF United States
  • EMBC United States
  • Employees
  • BCSF N/A
  • EMBC N/A
  • Industry
  • BCSF Finance/Investors Services
  • EMBC Medical/Dental Instruments
  • Sector
  • BCSF Finance
  • EMBC Health Care
  • Exchange
  • BCSF Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • BCSF 901.0M
  • EMBC 803.0M
  • IPO Year
  • BCSF 2018
  • EMBC N/A
  • Fundamental
  • Price
  • BCSF $14.28
  • EMBC $12.62
  • Analyst Decision
  • BCSF Buy
  • EMBC Buy
  • Analyst Count
  • BCSF 2
  • EMBC 2
  • Target Price
  • BCSF $15.50
  • EMBC $18.50
  • AVG Volume (30 Days)
  • BCSF 417.1K
  • EMBC 419.4K
  • Earning Date
  • BCSF 11-10-2025
  • EMBC 11-25-2025
  • Dividend Yield
  • BCSF 12.68%
  • EMBC 4.42%
  • EPS Growth
  • BCSF N/A
  • EMBC 20.90
  • EPS
  • BCSF 1.44
  • EMBC 1.62
  • Revenue
  • BCSF $278,347,000.00
  • EMBC $1,080,400,000.00
  • Revenue This Year
  • BCSF N/A
  • EMBC N/A
  • Revenue Next Year
  • BCSF N/A
  • EMBC N/A
  • P/E Ratio
  • BCSF $9.87
  • EMBC $8.38
  • Revenue Growth
  • BCSF N/A
  • EMBC N/A
  • 52 Week Low
  • BCSF $13.20
  • EMBC $9.20
  • 52 Week High
  • BCSF $19.21
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • BCSF 56.32
  • EMBC 35.82
  • Support Level
  • BCSF $13.91
  • EMBC $13.61
  • Resistance Level
  • BCSF $14.22
  • EMBC $14.78
  • Average True Range (ATR)
  • BCSF 0.31
  • EMBC 0.73
  • MACD
  • BCSF 0.06
  • EMBC -0.10
  • Stochastic Oscillator
  • BCSF 96.47
  • EMBC 1.78

About BCSF Bain Capital Specialty Finance Inc.

Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: